Covington, Ropes Lead Merck's $11.5B Acceleron Pharma Buy
Pharmaceutical giant Merck & Co., advised by Covington, plans to buy publicly traded cancer and rare disease biotech Acceleron Pharma Inc., represented by Ropes & Gray, for $11.5 billion, in a...To view the full article, register now.
Already a subscriber? Click here to view full article